AzTrials
AzTrials

Cesarean SectionACUCESARNCT06119971

Effect of Acupressure on the "Yin-Tang" and "Shen-Men" Points on Pre and Postoperative Anxiety in Elective Caesarean Section: a Prospective, Single-blind, Randomised, Controlled Trial

A study testing ACUPRESSURE in people with Cesarean Section and Pregnancy, run by University Hospital, Tours at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Preoperative anxiety occurs commonly in elective caesarean section and is associated with increased perioperative morbidity. Some groups have used non-pharmacological techniques such as acupressure for its treatment since drugs cross the placenta. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Cesarean Section, Pregnancy, Preoperative Anxiety
What is being tested?
ACUPRESSURE
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
44 participants
Where
1 siteFrance
Study dates
9 Jun 2022to 8 Mar 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • informed consent obtained
  • adult patients
  • ASA class I or II
  • scheduled caesarean section at CHRU Tours Maternity
  • under perispinal anaesthesia (spinal anaesthesia or spinal and epidural anaesthesia combined)

Who cannot join

  • higher or equal to ASA class III
  • heart rhythm disorder
  • treated with a psychotropic drug (anxiolytic, sedative, antidepressant, antipsychotic, mood stabilizer)
  • psychiatric history
  • drug or alcohol abuse
  • local contraindications to acupuncture (local signs of infection or inflammation, scars)
  • scheduled to caesarean section under general anaesthesia.
  • Patients will be excluded in the event of transition to general anaesthesia or cancellation of the procedure.

Trial locations and contacts

1 site in 1 country.

France1 site
  • University Hospital Tours

    Tours, 37044

Other trials in France

About this study

Preoperative anxiety occurs commonly in elective caesarean section and is associated with increased perioperative morbidity. Some groups have used non-pharmacological techniques such as acupressure for its treatment since drugs cross the placenta.

Read the detailed description

Preoperative anxiety occurs commonly in elective caesarean section and is associated with increased perioperative morbidity. Some groups have used non-pharmacological techniques such as acupressure for its treatment since drugs cross the placenta.

The aim of this study is to examine the efficacy of acupressure with co-stimulation of the "Yin-Tang" and "Shen-Men" points on the reduction in pre- and postoperative anxiety in elective caesarean section.

A single-blind, randomised, controlled, single-centre study will be conducted in ASA I or II patients undergoing elective caesarean section under perispinal anaesthesia. Patients will be randomised into two groups: the ACU+ group (co-stimulation of the "Yin-Tang" and "Shen-Men" points) and the ACU- group (stimulation of two sham points). Anxiety will be assessed using the State-Trait Anxiety Inventory (STAI) score and by measuring skin conductance (Electrodermal Activity [EDA]) during three periods: period 1 (at inclusion, in the patient's hospital room on the morning of the procedure), period 2 (before arrival in the operating theatre) and period 3 (in the postoperative recovery room). True or sham acupressure will be applied using adhesive beads positioned between periods 1 and 2 and left in place until the end of period 3.

Being tested
ACUPRESSURE
Keywords
Acupressure, STAI (State Trait Anxiety Inventory), EDA (Electrodermal Activity)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ACUPRESSUREDevice

    Acupressure using disposable devices consisting of a metal microbead and an adhesive material.

Study groups in NCT06119971
Study groupRoleWhat they receive
ACUPLUSExperimentalACU+ : patients receives stimulation on the true experimental points (Yin-Tang + Shen-Men)
Receives: Device: ACUPRESSURE
ACUMOINSPlacebo comparatorACU- : patients receives stimulation on placebo points ("sham" point)
Receives: Device: ACUPRESSURE

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. State Trait Anxiety Inventory (STAI) score

    Difference between the two groups (ACU+ versus ACU-) in STAI score

    Measured: At inclusion (the inclusion takes place on the morning of the surgery)

  2. State Trait Anxiety Inventory (STAI) score

    Difference between the two groups (ACU+ versus ACU-) in STAI score

    Measured: At the entrance in the operative room (this event takes place from 20 minutes to 12 hours after the inclusion, depending on the availability of the surgeons to start the C-section)

  3. State Trait Anxiety Inventory (STAI) score

    Difference between the two groups (ACU+ versus ACU-) in STAI score

    Measured: In the postoperative recovery room (this event takes place from 40 minutes to 16 hours after the inclusion, depending on the availability fo the surgeons to start the C-section and the duration of this one)

Secondary outcomes (3)
  1. Electrodermal Activity (EDA)

    Difference between the two groups (ACU+ versus ACU-) in EDA

    Measured: At inclusion

  2. Electrodermal Activity (EDA)

    Difference between the two groups (ACU+ versus ACU-) in EDA

    Measured: At the entrance in the operative room (this event takes place from 20 minutes to 12 hours after the inclusion, depending on the availability of the surgeons to start the C-section)

  3. Electrodermal Activity (EDA)

    Difference between the two groups (ACU+ versus ACU-) in EDA

    Measured: In the postoperative recovery room (this event takes place from 40 minutes to 16 hours after the inclusion, depending on the availability fo the surgeons to start the C-section and the duration of this one)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Nov 2023
  2. Study start9 Jun 2022
  3. Primary completion8 Mar 2023
  4. Study completion8 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
44 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06119971
Sponsor's protocol ID
ACUCESAR
Acronym
ACUCESAR
Status last verified
Oct 2023
First submitted
2 Oct 2023
Last updated
7 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing ACUPRESSURE in people with Cesarean Section and Pregnancy, run by University Hospital, Tours at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

State Trait Anxiety Inventory (STAI) score (time frame: At inclusion (the inclusion takes place on the morning of the surgery)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in